Coherus BioSciences Revenue vs. Price To Earning

CHRS Stock  USD 1.70  0.19  12.58%   
Based on Coherus BioSciences' profitability indicators, Coherus BioSciences' profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Coherus BioSciences' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2012-12-31
Previous Quarter
65 M
Current Value
70.8 M
Quarterly Volatility
46.3 M
 
Yuan Drop
 
Covid
At this time, Coherus BioSciences' Days Sales Outstanding is comparatively stable compared to the past year. Days Of Sales Outstanding is likely to gain to 388.13 in 2024, whereas Price To Sales Ratio is likely to drop 1.16 in 2024. Interest Income is likely to gain to about 21.3 M in 2024, whereas Accumulated Other Comprehensive Income is likely to drop (260.4 K) in 2024.
For Coherus BioSciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coherus BioSciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coherus BioSciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coherus BioSciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coherus BioSciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coherus BioSciences. If investors know Coherus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coherus BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
(0.09)
Revenue Per Share
2.678
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.14)
The market value of Coherus BioSciences is measured differently than its book value, which is the value of Coherus that is recorded on the company's balance sheet. Investors also form their own opinion of Coherus BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Coherus BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coherus BioSciences' market value can be influenced by many factors that don't directly affect Coherus BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coherus BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Coherus BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coherus BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Coherus BioSciences Price To Earning vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Coherus BioSciences's current stock value. Our valuation model uses many indicators to compare Coherus BioSciences value to that of its competitors to determine the firm's financial worth.
Coherus BioSciences is the top company in revenue category among its peers. It is rated fourth in price to earning category among its peers . The ratio of Revenue to Price To Earning for Coherus BioSciences is about  60,958,294 . At this time, Coherus BioSciences' Total Revenue is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Coherus BioSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Coherus Revenue vs. Competition

Coherus BioSciences is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 470.23 Million. Coherus BioSciences totals roughly 257.24 Million in revenue claiming about 55% of equities under Health Care industry.

Coherus Price To Earning vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Coherus BioSciences

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
257.24 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Coherus BioSciences

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
4.22 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Coherus Price To Earning Comparison

Coherus BioSciences is currently under evaluation in price to earning category among its peers.

Coherus BioSciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Coherus BioSciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Coherus BioSciences will eventually generate negative long term returns. The profitability progress is the general direction of Coherus BioSciences' change in net profit over the period of time. It can combine multiple indicators of Coherus BioSciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-248 K-260.4 K
Operating Income-203.2 M-193 M
Income Before Tax-238.3 M-226.4 M
Total Other Income Expense Net-35.1 M-33.3 M
Net Loss-237.9 M-226 M
Income Tax Expense-380 K-361 K
Net Loss-237.9 M-226 M
Non Operating Income Net Other-2.8 M-2.9 M
Net Loss-262.6 M-249.4 M
Interest Income20.2 M21.3 M
Net Interest Income-40.5 M-38.5 M
Change To Netincome95.4 M68.6 M
Net Loss(2.53)(2.65)
Income Quality 0.74  0.52 
Net Income Per E B T 1.00  0.81 

Coherus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Coherus BioSciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Coherus BioSciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Coherus BioSciences' important profitability drivers and their relationship over time.

Use Coherus BioSciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coherus BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will appreciate offsetting losses from the drop in the long position's value.

Coherus BioSciences Pair Trading

Coherus BioSciences Pair Trading Analysis

The ability to find closely correlated positions to Coherus BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coherus BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coherus BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coherus BioSciences to buy it.
The correlation of Coherus BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coherus BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coherus BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coherus BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Coherus BioSciences position

In addition to having Coherus BioSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Services Thematic Idea Now

Communication Services
Communication Services Theme
Companies that provide networking, telecom, and long distance services. The Communication Services theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Services Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Coherus Stock Analysis

When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.